The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Kinetic Analysis of Drug Release From Nanoparticles
Open accessAbstract
PURPOSE. Comparative drug release kinetics from nanoparticles was carried out using conventional and our novel models with the aim of finding a general model applicable to multi mechanistic release. Theoretical justification for the two best general models was also provided for the first time. METHODS. Ten conventional models and three models developed in our laboratory were applied to release data of 32 drugs from 106 nanoparticle formulations collected from literature. The accuracy of the models was assessed employing mean percent error (E) of each data set, overall mean percent error (OE) and number of Es less than 10 percent. RESULTS. Among the models the novel reciprocal powered time (RPT), Weibull (W) and log- probability (LP) ones produced OE values of 6.47, 6.39 and 6.77, respectively. The OEs of other models were higher than 10%. Also the number of errors less than 10% for the models was 84.9, 80.2 and 78.3 percents of total number of data sets. CONCLUSIONS. Considering the accuracy criteria the reciprocal powered time model could be suggested as a general model for analysis of multi mechanistic drug release from nanoparticles. Also W and LP models were the closest to the suggested model RPT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Dynamics of Capillary Flow
Washburn, E. W. (1921) · Physical Review · doi:10.1103/physrev.17.273 · Cited by 7,141
Modeling and comparison of dissolution profiles
Costa, P., & Sousa Lobo, J. M. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00095-1 · Cited by 5,509
Higuchi, T. (1963) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600521210 · Cited by 4,884
Ritger, P. L., & Peppas, N. A. (1987) · Journal of Controlled Release · doi:10.1016/0168-3659(87)90035-6 · Cited by 4,064
Recent advances on chitosan-based micro- and nanoparticles in drug delivery
Agnihotri, S. A., Mallikarjuna, N. N., & Aminabhavi, T. M. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.08.010 · Cited by 2,586
Rate of Release of Medicaments from Ointment Bases Containing Drugs in Suspension
Higuchi, T. (1961) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600501018 · Cited by 2,262
Analysis of Fickian and non-Fickian drug release from polymers.
Peppas, N. A. (1985) · PubMed · Cited by 2,139
THE RATE OF SOLUTION OF SOLID SUBSTANCES IN THEIR OWN SOLUTIONS.
Noyes, A. A., & Whitney, W. R. (1897) · Journal of the American Chemical Society · doi:10.1021/ja02086a003 · Cited by 1,884
A simple equation for the description of solute release. III. Coupling of diffusion and relaxation
Peppas, N. A., & Sahlin, J. J. (1989) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(89)90306-2 · Cited by 1,771
Govender, T. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00116-3 · Cited by 1,008
On the use of the Weibull function for the discernment of drug release mechanisms
Papadopoulou, V., Kosmidis, K., Vlachou, M., & Macheras, P. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.044 · Cited by 882
Mu, L., & Feng, S. S. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00320-6 · Cited by 725
Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles
Venkateswarlu, V., & Manjunath, K. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.01.005 · Cited by 558
Synthesis and characterization of chitosan–poly(acrylic acid) nanoparticles
Hu, Y., Jiang, X., Ding, Y., Ge, H., Yuan, Y., & Yang, C. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00071-6 · Cited by 513
Wagner, J. G. (1969) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600581021 · Cited by 496
PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution
Mainardes, R. M., & Evangelista, R. C. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.11.027 · Cited by 494
Letters to the Editor: Linearization of dissolution rate curves by the Weibull distribution
Langenbucher, F. (1972) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1972.tb08930.x · Cited by 463
Polymeric nanoparticles for cancer therapy
Parveen, S., & Sahoo, S. K. (2008) · Journal of Drug Targeting · doi:10.1080/10611860701794353 · Cited by 427
Nanotechnology in Ocular Drug Delivery
Patel, D., Pathak, D., & Giradkar, P. (2021) · Nanocarriers: Drug Delivery System · doi:10.1007/978-981-33-4497-6_18 · Cited by 362
Hecq, J., Deleers, M., Fanara, D., Vranckx, H., & Amighi, K. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.05.014 · Cited by 339
Virus-based nanoparticles (VNPs): Platform technologies for diagnostic imaging☆
MANCHESTER, M., & SINGH, P. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.014 · Cited by 292
LIU, J., GONG, T., WANG, C., ZHONG, Z., & ZHANG, Z. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.009 · Cited by 282
Leroux, J.-C., Allémann, E., De Jaeghere, F., Doelker, E., & Gurny, R. (1996) · Journal of Controlled Release · doi:10.1016/0168-3659(95)00164-6 · Cited by 268
Drug/Polymer Matrix Swelling and Dissolution
Harland, R. S., Gazzaniga, A., Sangalli, M. E., Colombo, P., & Peppas, N. A. (1988) · Pharmaceutical Research · doi:10.1023/a:1015913207052 · Cited by 253
CHEN, D.-B., YANG, T.-Z., LU, W.-L., & ZHANG, Q. (2001) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.49.1444 · Cited by 243
Lee, J., Cho, E. C., & Cho, K. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.10.012 · Cited by 218
Wei, H., Zhang, X., Cheng, C., Cheng, S.-X., & Zhuo, R.-X. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.08.030 · Cited by 217
Derakhshandeh, K., Erfan, M., & Dadashzadeh, S. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.09.004 · Cited by 200
Teixeira, M., Alonso, M. J., Pinto, M. M. M., & Barbosa, C. M. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.09.002 · Cited by 188
Preparation and characterization of solid lipid nanoparticles containing peptide
Hu, F. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.12.016 · Cited by 168
Hu, F. X., Neoh, K. G., & Kang, E. T. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.07.014 · Cited by 165
Zhang, Q., Shen, Z., & Nagai, T. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00614-7 · Cited by 159
Jeon, H.-J., Jeong, Y.-I., Jang, M.-K., Park, Y.-H., & Nah, J.-W. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00537-8 · Cited by 159
Heparin–deoxycholic acid chemical conjugate as an anticancer drug carrier and its antitumor activity
Park, K., Lee, G. Y., Kim, Y.-S., Yu, M., Park, R.-W., Kim, I.-S., Kim, S. Y., & Byun, Y. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.05.017 · Cited by 158
Lü, W., Tan, Y.-Z., Hu, K., & Jiang, X. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.01.043 · Cited by 156
Adibkia, K., Shadbad, M. R. S., Nokhodchi, A., Javadzedeh, A., Barzegar-Jalali, M., Barar, J., Mohammadi, G., & Omidi, Y. (2007) · Journal of drug targeting · doi:10.1080/10611860701453125 · Cited by 156
Self-citationMatsumoto, J., Nakada, Y., Sakurai, K., Nakamura, T., & Takahashi, Y. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00153-2 · Cited by 137
Jaiswal, J. K., Gupta, S. K., & Kreuter, J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.01.017 · Cited by 126
Xiong, X. Y., Tam, K. C., & Gan, L. H. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.11.018 · Cited by 120
Zhang, Y., & Zhuo, R. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.06.004 · Cited by 113
Nanomedicine – prospective therapeutic and diagnostic applications
Emerich, D. F. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.1.1 · Cited by 113
Chaw, C. S., Chooi, K. M., Liu, X., Tan, D., Wang, L., & Yang, Y. Y. (2003) · Biomaterials · doi:10.1016/j.biomaterials.2003.10.095 · Cited by 111
On the Heterogeneity of Drug Dissolution and Release
Macheras, P. E., & Dokoumetzidis, A. (2000) · Pharmaceutical Research · doi:10.1023/a:1007596709657 · Cited by 90
Effect of porosity on the release kinetics of propafenone-loaded PEG-g-PLA nanoparticles
Sant, S., Nadeau, V., & Hildgen, P. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.02.017 · Cited by 86
Development of ciprofloxacin-loaded nanoparticles: physicochemical study of the drug carrier
Page-Clisson, M.-E., Pinto‐Alphandary, H., Ourévitch, M., Andremont, A., & Couvreur, P. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00065-0 · Cited by 74
Ibuprofen-loaded nanoparticles prepared by a co-precipitation method and their release properties
Jiang, B., Hu, L., Gao, C., & Shen, J. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.08.008 · Cited by 72
Arbós, P., Campanero, M. Á., Arangoa, M. A., et al. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.01.006 · Cited by 67
Raffin, R. P., Colomé, L. M., Pohlmann, A. R., & Guterres, S. S. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.01.013 · Cited by 51
Design of naltrexone-loaded hydrolyzable crosslinked nanoparticles
Yin, W., Akala, E. O., & Taylor, R. E. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00297-1 · Cited by 39
Dillen, K., Weyenberg, W., Vandervoort, J., & Ludwig, A. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.035 · Cited by 38
Nanotechnology: challenging the limit of creativity in targeted drug delivery
Lee, V. H. L. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.07.003 · Cited by 23
ZHENQING, H., Zhenxi, Z., Chuanxin, Z., & Huang, M. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.03.033 · Cited by 19
Cited by
Pourtalebi Jahromi, L., Ghazali, M., Ashrafi, H., & Azadi, A. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e03451 · Cited by 317
Calcium carbonate nanoparticles as cancer drug delivery system
Maleki Dizaj, S., Barzegar-Jalali, M., Zarrintan, M. H., Adibkia, K., & Lotfipour, F. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1049530 · Cited by 310
Self-citationCholesterol modulates the liposome membrane fluidity and permeability for a hydrophilic molecule
Kaddah, S., Khreich, N., Kaddah, F., Charcosset, C., & Greige-Gerges, H. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.01.017 · Cited by 308
A Review of In Vitro Drug Release Test Methods for Nano-Sized Dosage Forms
D’Souza, S. (2014) · Advances in Pharmaceutics · doi:10.1155/2014/304757 · Cited by 262
Protein‐Based Delivery Systems for the Nanoencapsulation of Food Ingredients
Fathi, M., Donsi, F., & McClements, D. J. (2018) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12360 · Cited by 254
Metadata
- Authors
- Barzegar-Jalali, M.
- Venue
- Journal of Pharmacy & Pharmaceutical Sciences
- Publisher
- Frontiers Media SA
- Published
- 2008-05-07
- Volume
- 11
- Issue
- 1
- Pages
- 167
- ISSN
- 1482-1826 (ISSN-L)
- OpenAlex
- W1556912674
- Cited by
- 343
- References
- 52
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.